Sale!

RMND1 Gene Combined oxidative phosphorylation deficiency type 11 Genetic Test Cost

Name: RMND1 Gene Combined oxidative phosphorylation deficiency type 11 Genetic Test Cost
Brand: Metabolic Disorders
SKU: TEST-2235
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RMND1 gene plays a crucial role in the proper functioning of mitochondria, the energy-producing organelles within cells. Mutations in the RMND1 gene can lead to Combined Oxidative Phosphorylation Deficiency Type 11 (COXPD11), a rare genetic disorder that affects multiple body systems and can result in a wide range of health issues, including developmental delay, muscle weakness, hearing loss, and problems with the heart, liver, and brain.

To diagnose this condition accurately, genetic testing for mutations in the RMND1 gene is essential. DNA Labs UAE offers a specialized genetic test to identify mutations in the RMND1 gene, aiding in the diagnosis of COXPD11. This test is crucial for understanding the specific genetic alterations in affected individuals, allowing for tailored management and treatment plans.

The cost of the RMND1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the RMND1 gene that could be responsible for the development of COXPD11. By choosing DNA Labs UAE for this genetic test, individuals can expect a high level of accuracy, expertise, and support throughout the testing process, enabling informed decisions about health and treatment options.

Description

RMND1 Gene Combined oxidative phosphorylation deficiency type 11 Genetic Test

Test Name: RMND1 Gene Combined oxidative phosphorylation deficiency type 11 Genetic Test

Components: RMND1 gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology (Next-Generation Sequencing)

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RMND1 Gene Combined oxidative phosphorylation deficiency type 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 11.

Test Details:

The RMND1 gene is associated with Combined Oxidative Phosphorylation Deficiency Type 11 (COXPD11), a rare genetic disorder characterized by impaired energy production in the mitochondria. This condition affects various organs and tissues, leading to a wide range of symptoms.

NGS Genetic Testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of COXPD11, NGS Genetic Testing can be used to identify mutations or variations in the RMND1 gene that may be responsible for the condition.

By identifying specific genetic changes in the RMND1 gene, NGS Genetic Testing can help in confirming a diagnosis of COXPD11. It can also provide valuable information for genetic counseling, family planning, and potential treatment options.

However, it is important to note that the interpretation of genetic test results should be done by a qualified healthcare professional or genetic counselor.

Test Name	RMND1 Gene Combined oxidative phosphorylation deficiency type 11 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for RMND1 Gene Combined oxidative phosphorylation deficiency type 11 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 11
Test Details	The RMND1 gene is associated with Combined Oxidative Phosphorylation Deficiency Type 11 (COXPD11), which is a rare genetic disorder characterized by impaired energy production in the mitochondria. This condition affects various organs and tissues, leading to a wide range of symptoms. NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of COXPD11, NGS Genetic Testing can be used to identify mutations or variations in the RMND1 gene that may be responsible for the condition. By identifying specific genetic changes in the RMND1 gene, NGS Genetic Testing can help in confirming a diagnosis of COXPD11. It can also provide valuable information for genetic counseling, family planning, and potential treatment options. However, it is important to note that the interpretation of genetic test results should be done by a qualified healthcare professional or genetic counselor.